Monthly or quarterly intelligence digest
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
“
Risks triaged
Intelligence Brief
StatusRisks triaged
Our craft
Built around real regulatory affairs practice.
Service Detail
Track changing requirements before they become risks.
Regulatory expectations move quickly. PharmaRevix monitors authority updates, guidance changes, market signals, and competitor movement so your team can act before issues become urgent.
You operate across several markets
You need structured monitoring instead of ad hoc updates
You are preparing for upcoming guidance changes
You need leadership summaries with clear actions
Deliverables
Practical outputs your team can use immediately.
Product-specific impact assessment
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Guidance change tracker
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Authority and competitor signal brief
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Action register with priorities
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Escalation memo for high-risk changes
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Workflow
A clear sequence from assessment to handoff.
01
Assess
Define products, markets, and intelligence sources
02
Plan
Monitor authority updates and relevant industry signals
03
Execute
Assess impact on dossiers, labels, safety, and QMS
04
Maintain
Convert findings into tracked actions
Proof Package
Every engagement leaves an evidence trail.
The work is designed for real review: authority questions, partner due diligence, quality audits, and internal leadership updates.
Horizon scanAction logSenior-led
Continuous monitoring of authority and regional guidance
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Impact assessment for products, dossiers, and procedures
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Change-control recommendations with action owners
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Executive summaries for regulatory and quality teams
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Related Services
Connect this work with adjacent regulatory and safety needs.
Regulatory Strategy
Choose the right pathway before you spend on dossiers, studies, or local filings. PharmaRevix maps options, risks, data gaps, and authority expectations so teams can move with confidence.
Explore serviceGlobal Expansion
Leverage existing EU or US approvals and adapt the dossier intelligently for each country. PharmaRevix helps you prioritize markets, coordinate local representatives, and keep submissions moving.
Explore serviceQMS & GAP Analysis
PharmaRevix develops SOPs, performs GAP analysis, supports internal audits, and prepares teams for mock inspection across pharmacovigilance and regulatory operations.
Explore serviceFAQ
Common questions about Regulatory Intelligence.
Short answers for teams deciding whether this is the right next step.
Ask us anythingPharmaRevix supports this with senior review, practical documentation, and a clear evidence trail so the output can be used by internal teams, partners, and authorities.
The right timing depends on product stage, target markets, and regulatory commitments. PharmaRevix usually starts with a focused review and then sets a workplan with owners, dates, and evidence expectations.
Yes. PharmaRevix can scope this as a standalone workstream or connect it with adjacent regulatory affairs, pharmacovigilance, QMS, and submission activities.
Free 30-minute consultation
Need regulatory intelligence support?
Talk with PharmaRevix about scope, timelines, and the cleanest next step for your market or safety obligation.